Arterial’naya Gipertenziya (Arterial Hypertension)

ISSN 1607-419x · Russian Federation · active 2003–2026

Metrics

Scimago quartile (2025)
Q4
Cites per paper (2y)
0.6
SJR
0.149
h-index
15

“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric (how the two differ). Citation rates differ enormously between fields, so compare within a discipline. What the other figures mean: journal quartile, SJR, h-index and article processing charge.

Data as of 25 October 2026 (venue index build).

Scimago Journal Rank 2025

In the Scimago Journal Rank 2025 edition, Arterial’naya Gipertenziya (Arterial Hypertension) is Q4 in all 2 of its subject categories.

Scimago 2025 quartile and rank of Arterial’naya Gipertenziya (Arterial Hypertension) in each subject category
Subject categoryQuartileRank in category
Internal MedicineQ4#150 of 181
Cardiology and Cardiovascular MedicineQ4#347 of 414
Cites per document (2 years, Scopus)
0.46
Documents indexed in 2025 (Scopus)
39

The quartile is the one Scimago prints for each category. Rank is the journal's position by SJR among the journals Scimago lists in that category (#1 is the highest); “—” means we hold no rank consistent with that quartile. The document count is what Scopus indexed that year, which can be lower than a journal's full output. Source: SCImago Journal Rank 2025 edition, from Scopus data (scimagojr.com, CC BY-NC).

Arterial’naya Gipertenziya (Arterial Hypertension) is Q4 in all 2 of its Scimago subject categories (2025 edition; best category Internal Medicine: Q4, #150 of 181), with SJR 0.149 (Scimago) and an h-index of 15 (OpenAlex). Listed in Scopus.

Is this the right journal for your paper?

The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.

Try the Journal Finder →

Indexing & access

Indexed in
Scopus
Access status:
gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.

Official journal site →

Scope

bloodpressurehypertensioncardiologycardiovascularmedicinehealthcarepublichealthepidemiologyheartrate

Frequently asked

Is Arterial’naya Gipertenziya (Arterial Hypertension) a predatory journal?

Our screening does not flag Arterial’naya Gipertenziya (Arterial Hypertension). That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, which is a positive signal.

Is Arterial’naya Gipertenziya (Arterial Hypertension) indexed in Scopus or Web of Science?

Per our venue index, Arterial’naya Gipertenziya (Arterial Hypertension) appears in: Scopus. Index membership changes over time — confirm on the index's own site before relying on it.

What is the impact factor of Arterial’naya Gipertenziya (Arterial Hypertension)?

Papers in Arterial’naya Gipertenziya (Arterial Hypertension) are cited about 0.6 times each within two years of publication, and Scimago places it in Q4, with an h-index of 15. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.

What Scimago quartile is Arterial’naya Gipertenziya (Arterial Hypertension) (Q1, Q2, Q3, or Q4)?

In the Scimago Journal Rank 2025 edition, Arterial’naya Gipertenziya (Arterial Hypertension) is Q4 in all 2 of its subject categories. By category: Internal Medicine: Q4, #150 of 181; Cardiology and Cardiovascular Medicine: Q4, #347 of 414. Quartiles split the journals in a subject category into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Arterial’naya Gipertenziya (Arterial Hypertension) is cited about 0.6 times per paper over two years, with an h-index of 15.

What is the Web of Science (JCR) quartile of Arterial’naya Gipertenziya (Arterial Hypertension)?

The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Arterial’naya Gipertenziya (Arterial Hypertension). The open equivalent is its Scimago quartile, Q4, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.

Is Arterial’naya Gipertenziya (Arterial Hypertension) open access?

Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.

Ready to submit? Tools for your next paper

How Pre-Check worksHow AI Review works

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Similar venues

Compare it with its peers: Ranked Cardiology and Cardiovascular Medicine journals — ranked by Scimago quartile and cites per paper, predatory venues excluded.

Command palette

Jump anywhere, run any action.